Table 2.
Baseline characteristics of subjects analyzed in the study.
| Characteristic | KW3110 | Placebo | p Values |
|---|---|---|---|
| Mean ± SD | Mean ± SD | ||
| Number of subjects (male/female) | 28 (13/15) | 31 (15/16) | 0.880 |
| Age (years) | 40.3 ± 2.7 | 40.6 ± 2.8 | 0.651 |
| Body weight (kg) | 58.27 ± 10.29 | 59.34 ± 10.60 | 0.695 |
| BMI (kg/m2) | 21.48 ± 2.53 | 21.86 ± 2.40 | 0.564 |
Data are expressed as the mean ± standard deviation (SD) with the exception of sex. The comparisons between two groups were performed by an unpaired Student’s t-test except for the number of subjects (male/female). The number of subjects (male/female) was evaluated using a χ2 test. There was no significant difference in any parameters between the two groups. BMI = body/mass index. KW3110 = L. paracasei KW3110-treated group. placebo = control group.